JPWO2019089465A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2019089465A5 JPWO2019089465A5 JP2020543256A JP2020543256A JPWO2019089465A5 JP WO2019089465 A5 JPWO2019089465 A5 JP WO2019089465A5 JP 2020543256 A JP2020543256 A JP 2020543256A JP 2020543256 A JP2020543256 A JP 2020543256A JP WO2019089465 A5 JPWO2019089465 A5 JP WO2019089465A5
- Authority
- JP
- Japan
- Prior art keywords
- sensor
- electrochemical sensor
- current
- target
- concentration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000005259 measurement Methods 0.000 claims description 76
- 241000894007 species Species 0.000 claims description 54
- 229920002395 Aptamer Polymers 0.000 claims description 48
- 230000027455 binding Effects 0.000 claims description 40
- 210000004369 Blood Anatomy 0.000 claims description 34
- 239000008280 blood Substances 0.000 claims description 34
- 239000003814 drug Substances 0.000 claims description 31
- 229940079593 drugs Drugs 0.000 claims description 31
- 230000005284 excitation Effects 0.000 claims description 19
- 238000000034 method Methods 0.000 claims description 19
- 230000001419 dependent Effects 0.000 claims description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- 210000001519 tissues Anatomy 0.000 claims description 9
- 239000002207 metabolite Substances 0.000 claims description 8
- 230000001717 pathogenic Effects 0.000 claims description 8
- 244000052769 pathogens Species 0.000 claims description 8
- 210000002966 Serum Anatomy 0.000 claims description 7
- 210000004027 cells Anatomy 0.000 claims description 6
- 230000036499 Half live Effects 0.000 claims description 5
- 229940088597 Hormone Drugs 0.000 claims description 5
- 239000005556 hormone Substances 0.000 claims description 5
- 108020004707 nucleic acids Proteins 0.000 claims description 5
- 150000007523 nucleic acids Chemical class 0.000 claims description 5
- 108090000623 proteins and genes Proteins 0.000 claims description 5
- 102000004169 proteins and genes Human genes 0.000 claims description 5
- 150000003384 small molecules Chemical class 0.000 claims description 5
- 210000003722 Extracellular Fluid Anatomy 0.000 claims description 4
- 210000003296 Saliva Anatomy 0.000 claims description 4
- 210000004243 Sweat Anatomy 0.000 claims description 4
- 210000002700 Urine Anatomy 0.000 claims description 4
- 239000012530 fluid Substances 0.000 claims description 4
- 235000013305 food Nutrition 0.000 claims description 4
- 210000001175 Cerebrospinal Fluid Anatomy 0.000 claims description 3
- 210000000416 Exudates and Transudates Anatomy 0.000 claims description 3
- 102000015731 Peptide Hormones Human genes 0.000 claims description 3
- 108010038988 Peptide Hormones Proteins 0.000 claims description 3
- 235000013361 beverage Nutrition 0.000 claims description 3
- 235000014633 carbohydrates Nutrition 0.000 claims description 3
- 150000001720 carbohydrates Chemical class 0.000 claims description 3
- 239000000356 contaminant Substances 0.000 claims description 3
- 239000003673 groundwater Substances 0.000 claims description 3
- 239000003102 growth factor Substances 0.000 claims description 3
- 230000003834 intracellular Effects 0.000 claims description 3
- 150000002632 lipids Chemical class 0.000 claims description 3
- 239000002858 neurotransmitter agent Substances 0.000 claims description 3
- 235000015097 nutrients Nutrition 0.000 claims description 3
- 239000002351 wastewater Substances 0.000 claims description 3
- 230000001939 inductive effect Effects 0.000 claims description 2
- 239000000523 sample Substances 0.000 description 64
- 238000000970 chrono-amperometry Methods 0.000 description 30
- 230000027756 respiratory electron transport chain Effects 0.000 description 28
- 238000004365 square wave voltammetry Methods 0.000 description 21
- 239000012071 phase Substances 0.000 description 20
- 230000001052 transient Effects 0.000 description 19
- NLVFBUXFDBBNBW-PBSUHMDJSA-N Tobramycin Chemical compound N[C@@H]1C[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N NLVFBUXFDBBNBW-PBSUHMDJSA-N 0.000 description 14
- 229960000707 Tobramycin Drugs 0.000 description 14
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 12
- 230000036462 Unbound Effects 0.000 description 10
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 10
- 229910052737 gold Inorganic materials 0.000 description 10
- 239000010931 gold Substances 0.000 description 10
- 238000005070 sampling Methods 0.000 description 10
- RBTBFTRPCNLSDE-UHFFFAOYSA-N 3,7-bis(dimethylamino)phenothiazin-5-ium Chemical compound C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 RBTBFTRPCNLSDE-UHFFFAOYSA-N 0.000 description 9
- 229940042115 Methylene blue Drugs 0.000 description 9
- 238000001514 detection method Methods 0.000 description 9
- 229960000907 methylthioninium chloride Drugs 0.000 description 9
- 238000004458 analytical method Methods 0.000 description 8
- 239000000203 mixture Substances 0.000 description 8
- 239000000758 substrate Substances 0.000 description 8
- 230000002123 temporal effect Effects 0.000 description 8
- HKZLPVFGJNLROG-UHFFFAOYSA-M Silver chloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 description 7
- 238000001802 infusion Methods 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 7
- 230000001603 reducing Effects 0.000 description 7
- 238000000611 regression analysis Methods 0.000 description 7
- 238000004164 analytical calibration Methods 0.000 description 6
- 229920003013 deoxyribonucleic acid Polymers 0.000 description 6
- 230000000275 pharmacokinetic Effects 0.000 description 6
- 229910052697 platinum Inorganic materials 0.000 description 6
- 238000006722 reduction reaction Methods 0.000 description 6
- 238000003860 storage Methods 0.000 description 6
- 230000001404 mediated Effects 0.000 description 5
- 230000002829 reduced Effects 0.000 description 5
- 210000004731 Jugular Veins Anatomy 0.000 description 4
- UIIMBOGNXHQVGW-UHFFFAOYSA-M buffer Substances [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- 238000011088 calibration curve Methods 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 230000003993 interaction Effects 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 230000001429 stepping Effects 0.000 description 4
- 241000700159 Rattus Species 0.000 description 3
- 239000012491 analyte Substances 0.000 description 3
- 238000004166 bioassay Methods 0.000 description 3
- 238000004364 calculation method Methods 0.000 description 3
- 230000001276 controlling effect Effects 0.000 description 3
- 230000000875 corresponding Effects 0.000 description 3
- 238000006073 displacement reaction Methods 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 238000001647 drug administration Methods 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 238000009413 insulation Methods 0.000 description 3
- 239000003446 ligand Substances 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 230000011664 signaling Effects 0.000 description 3
- BQCADISMDOOEFD-UHFFFAOYSA-N silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 3
- 229910052709 silver Inorganic materials 0.000 description 3
- 239000004332 silver Substances 0.000 description 3
- 230000001225 therapeutic Effects 0.000 description 3
- -1 viologen Chemical compound 0.000 description 3
- 229940095074 Cyclic AMP Drugs 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 230000036826 Excretion Effects 0.000 description 2
- KTWOOEGAPBSYNW-UHFFFAOYSA-N Ferrocene Chemical compound [Fe+2].C=1C=C[CH-]C=1.C=1C=C[CH-]C=1 KTWOOEGAPBSYNW-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 102000015636 Oligopeptides Human genes 0.000 description 2
- 108010038807 Oligopeptides Proteins 0.000 description 2
- 241000209094 Oryza Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- KHPCPRHQVVSZAH-HUOMCSJISA-N Rosin Natural products O(C/C=C/c1ccccc1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 KHPCPRHQVVSZAH-HUOMCSJISA-N 0.000 description 2
- UAWABSHMGXMCRK-UHFFFAOYSA-L Samarium(II) iodide Chemical compound I[Sm]I UAWABSHMGXMCRK-UHFFFAOYSA-L 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 210000003462 Veins Anatomy 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- IVOMOUWHDPKRLL-KQYNXXCUSA-N cAMP Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=CN=C2N)=C2N=C1 IVOMOUWHDPKRLL-KQYNXXCUSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 125000002091 cationic group Chemical group 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000004891 communication Methods 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 238000000840 electrochemical analysis Methods 0.000 description 2
- 230000029142 excretion Effects 0.000 description 2
- QTWZICCBKBYHDM-UHFFFAOYSA-N hydromethylthionine Chemical compound C1=C(N(C)C)C=C2SC3=CC(N(C)C)=CC=C3NC2=C1 QTWZICCBKBYHDM-UHFFFAOYSA-N 0.000 description 2
- 238000003384 imaging method Methods 0.000 description 2
- 238000011065 in-situ storage Methods 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 238000002032 lab-on-a-chip Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000007791 liquid phase Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000005012 migration Effects 0.000 description 2
- 230000003278 mimic Effects 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000003957 neurotransmitter release Effects 0.000 description 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
- 229920000123 polythiophene Polymers 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 238000009738 saturating Methods 0.000 description 2
- 231100000486 side effect Toxicity 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000011550 stock solution Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000004448 titration Methods 0.000 description 2
- 238000004832 voltammetry Methods 0.000 description 2
- 229920000160 (ribonucleotides)n+m Polymers 0.000 description 1
- AZQWKYJCGOJGHM-UHFFFAOYSA-N 1,4-Benzoquinone Chemical compound O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 description 1
- UGZAJZLUKVKCBM-UHFFFAOYSA-N 6-sulfanylhexan-1-ol Chemical compound OCCCCCCS UGZAJZLUKVKCBM-UHFFFAOYSA-N 0.000 description 1
- RZVHIXYEVGDQDX-UHFFFAOYSA-N Anthraquinone Chemical compound C1=CC=C2C(=O)C3=CC=CC=C3C(=O)C2=C1 RZVHIXYEVGDQDX-UHFFFAOYSA-N 0.000 description 1
- 210000001367 Arteries Anatomy 0.000 description 1
- 230000036868 Blood Concentration Effects 0.000 description 1
- 230000035639 Blood Levels Effects 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 210000003169 Central Nervous System Anatomy 0.000 description 1
- 206010008531 Chills Diseases 0.000 description 1
- 210000003763 Chloroplasts Anatomy 0.000 description 1
- 108010021446 Cytochromes c' Proteins 0.000 description 1
- STQGQHZAVUOBTE-VGBVRHCVSA-N DAUNOMYCIN Chemical compound O([C@H]1C[C@@](O)(CC=2C(O)=C3C(=O)C=4C=CC=C(C=4C(=O)C3=C(O)C=21)OC)C(C)=O)[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1 STQGQHZAVUOBTE-VGBVRHCVSA-N 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 230000036469 Elimination phase Effects 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- ZMMJGEGLRURXTF-UHFFFAOYSA-N Ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 1
- 230000036740 Metabolism Effects 0.000 description 1
- 210000003470 Mitochondria Anatomy 0.000 description 1
- 210000003463 Organelles Anatomy 0.000 description 1
- 229940055729 Papain Drugs 0.000 description 1
- 108090000526 Papain Proteins 0.000 description 1
- 210000002381 Plasma Anatomy 0.000 description 1
- 108090000051 Plastocyanin Proteins 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 239000005092 Ruthenium Substances 0.000 description 1
- PZBFGYYEXUXCOF-UHFFFAOYSA-N TCEP Chemical compound OC(=O)CCP(CCC(O)=O)CCC(O)=O PZBFGYYEXUXCOF-UHFFFAOYSA-N 0.000 description 1
- 231100000765 Toxin Toxicity 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminum Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 239000002647 aminoglycoside antibiotic agent Substances 0.000 description 1
- 102000004965 antibodies Human genes 0.000 description 1
- 108090001123 antibodies Proteins 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000000712 assembly Effects 0.000 description 1
- 230000003115 biocidal Effects 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 239000000090 biomarker Substances 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 230000003139 buffering Effects 0.000 description 1
- 230000001413 cellular Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000000295 complement Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 239000000599 controlled substance Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 230000002596 correlated Effects 0.000 description 1
- 150000003983 crown ethers Chemical group 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 238000002484 cyclic voltammetry Methods 0.000 description 1
- 102000022270 cytochrome c family Human genes 0.000 description 1
- 108091010617 cytochrome c family Proteins 0.000 description 1
- 230000003247 decreasing Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 238000009513 drug distribution Methods 0.000 description 1
- 230000036267 drug metabolism Effects 0.000 description 1
- 239000002359 drug metabolite Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000000835 electrochemical detection Methods 0.000 description 1
- 238000002848 electrochemical method Methods 0.000 description 1
- 239000007772 electrode material Substances 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000002708 enhancing Effects 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 238000007306 functionalization reaction Methods 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 239000000411 inducer Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 238000002595 magnetic resonance imaging Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000035786 metabolism Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 125000002524 organometallic group Chemical group 0.000 description 1
- 210000000056 organs Anatomy 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- 235000019834 papain Nutrition 0.000 description 1
- 238000002161 passivation Methods 0.000 description 1
- 230000035506 pharmacokinetic model Effects 0.000 description 1
- 230000036231 pharmacokinetics Effects 0.000 description 1
- 230000036470 plasma concentration Effects 0.000 description 1
- 231100000719 pollutant Toxicity 0.000 description 1
- 150000004032 porphyrins Chemical class 0.000 description 1
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M potassium chloride Chemical class [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000001681 protective Effects 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 239000003638 reducing agent Substances 0.000 description 1
- 150000003303 ruthenium Chemical class 0.000 description 1
- KJTLSVCANCCWHF-UHFFFAOYSA-N ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 description 1
- 229910052707 ruthenium Inorganic materials 0.000 description 1
- 229920000260 silastic Polymers 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 229910000679 solder Inorganic materials 0.000 description 1
- 238000000638 solvent extraction Methods 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 230000003068 static Effects 0.000 description 1
- 150000003573 thiols Chemical class 0.000 description 1
- 230000036962 time dependent Effects 0.000 description 1
- 229910052718 tin Inorganic materials 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N tin hydride Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 108020003112 toxins Proteins 0.000 description 1
- WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 1
- 229910052721 tungsten Inorganic materials 0.000 description 1
- 239000010937 tungsten Substances 0.000 description 1
- 230000035500 two compartment model Effects 0.000 description 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023130593A JP2023144023A (ja) | 2017-10-30 | 2023-08-10 | 電気化学的センサーを用いた、分析物の較正不要なインビボ測定 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762578665P | 2017-10-30 | 2017-10-30 | |
| US62/578,665 | 2017-10-30 | ||
| PCT/US2018/058020 WO2019089465A1 (en) | 2017-10-30 | 2018-10-29 | Calibration free in-vivo measurement of analytes using electrochemical sensors |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023130593A Division JP2023144023A (ja) | 2017-10-30 | 2023-08-10 | 電気化学的センサーを用いた、分析物の較正不要なインビボ測定 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021501334A JP2021501334A (ja) | 2021-01-14 |
| JP2021501334A5 JP2021501334A5 (zh) | 2021-12-09 |
| JPWO2019089465A5 true JPWO2019089465A5 (zh) | 2023-01-19 |
Family
ID=66333628
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020543256A Pending JP2021501334A (ja) | 2017-10-30 | 2018-10-29 | 電気化学的センサーを用いた、分析物の較正不要なインビボ測定 |
| JP2023130593A Pending JP2023144023A (ja) | 2017-10-30 | 2023-08-10 | 電気化学的センサーを用いた、分析物の較正不要なインビボ測定 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023130593A Pending JP2023144023A (ja) | 2017-10-30 | 2023-08-10 | 電気化学的センサーを用いた、分析物の較正不要なインビボ測定 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20210196161A1 (zh) |
| EP (1) | EP3703558A4 (zh) |
| JP (2) | JP2021501334A (zh) |
| KR (1) | KR20200088358A (zh) |
| CN (1) | CN111683592B (zh) |
| AU (1) | AU2018359211A1 (zh) |
| CA (1) | CA3081401A1 (zh) |
| WO (1) | WO2019089465A1 (zh) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020104934A1 (en) | 2018-11-19 | 2020-05-28 | Zio Health Ltd | Self-parative calibration method of an aptamer sensor |
| JP2022537930A (ja) * | 2019-06-12 | 2022-08-31 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | Ｅ－ｄｎａ型センサーにおける電子移動反応速度の調節 |
| CN111999367A (zh) * | 2020-09-27 | 2020-11-27 | 上海兆莹自控设备有限公司 | 气体检测仪电化学传感器剩余使用寿命的测算方法 |
| WO2022093124A1 (en) * | 2020-10-30 | 2022-05-05 | National University Of Singapore | A disposable point-of-care rapid antigen test kit for the detection of sars-cov-2 infection |
| WO2022178327A1 (en) * | 2021-02-19 | 2022-08-25 | The Johns Hopkins University | Methods and related aspects of detecting target molecules using cyclic voltammetry |
| CN113219033B (zh) * | 2021-04-30 | 2022-08-30 | 福州大学 | 一种电化学适配体传感器的免校正定量测量方法 |
| KR102596331B1 (ko) | 2022-05-17 | 2023-10-31 | 재단법인대구경북과학기술원 | Fscv 데이터의 이차미분기반 신경전달물질의 농도 측정 결과를 제공하는 신경전달물질 농도 측정 장치 및 방법 |
| WO2024055110A1 (en) * | 2022-09-15 | 2024-03-21 | Societe De Commercialisation Des Produits De La Recherche Appliquee Socpra Sciences Et Genie, S.E.C. | Sensor, kit, and method for biomarker detection in saliva |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5470484A (en) * | 1994-01-13 | 1995-11-28 | Buckman Laboratories International, Inc. | Method and apparatus for controlling the feed of water treatment chemicals using a voltammetric sensor |
| US6740518B1 (en) * | 1998-09-17 | 2004-05-25 | Clinical Micro Sensors, Inc. | Signal detection techniques for the detection of analytes |
| US8003374B2 (en) * | 2003-03-25 | 2011-08-23 | The Regents Of The University Of California | Reagentless, reusable, bioelectronic detectors |
| US7749371B2 (en) * | 2005-09-30 | 2010-07-06 | Lifescan, Inc. | Method and apparatus for rapid electrochemical analysis |
| US7774038B2 (en) * | 2005-12-30 | 2010-08-10 | Medtronic Minimed, Inc. | Real-time self-calibrating sensor system and method |
| US20070299617A1 (en) * | 2006-06-27 | 2007-12-27 | Willis John P | Biofouling self-compensating biosensor |
| EP2043518A1 (en) * | 2006-07-21 | 2009-04-08 | Anaxsys Technology Limited | Gas sensor |
| MX347099B (es) * | 2006-10-24 | 2017-04-12 | Ascensia Diabetes Care Holdings Ag | Amperimetria de decadencia transitoria. |
| MX2010000972A (es) * | 2007-07-26 | 2010-03-01 | Home Diagnostics Inc | Sistema y metodos que determinan concentracion de analito utilizando amperometria resuelta en tiempo. |
| US8101062B2 (en) * | 2007-07-26 | 2012-01-24 | Nipro Diagnostics, Inc. | System and methods for determination of analyte concentration using time resolved amperometry |
| US9605295B2 (en) * | 2007-11-07 | 2017-03-28 | Cleveland State University | Electrochemical system and method thereof |
| US8280474B2 (en) * | 2008-06-02 | 2012-10-02 | Abbott Diabetes Care Inc. | Reference electrodes having an extended lifetime for use in long term amperometric sensors |
| WO2014143175A1 (en) * | 2013-03-12 | 2014-09-18 | Mine Safety Appliances Company | Gas sensor interrogation |
| US20160166186A1 (en) * | 2013-03-14 | 2016-06-16 | The Regents Of The University Of California | In-vivo monitoring of molecular targets |
| EP2801369A1 (en) * | 2013-05-06 | 2014-11-12 | Centre National De La Recherche Scientifique | TAFA4 compounds and uses thereof for treating pain |
| US20150276650A1 (en) * | 2014-03-28 | 2015-10-01 | Broadmaster Biotech Corp. | Method for fast measurement of specimen concentration |
| EP3320117B1 (en) * | 2015-07-06 | 2023-01-25 | Georgia State University Research Foundation, Inc. | Systems for detecting and quantifying nucleic acids |
-
2018
- 2018-10-29 JP JP2020543256A patent/JP2021501334A/ja active Pending
- 2018-10-29 US US16/756,681 patent/US20210196161A1/en active Pending
- 2018-10-29 CN CN201880084672.1A patent/CN111683592B/zh active Active
- 2018-10-29 KR KR1020207015647A patent/KR20200088358A/ko not_active Application Discontinuation
- 2018-10-29 CA CA3081401A patent/CA3081401A1/en active Pending
- 2018-10-29 AU AU2018359211A patent/AU2018359211A1/en active Pending
- 2018-10-29 EP EP18874074.0A patent/EP3703558A4/en active Pending
- 2018-10-29 WO PCT/US2018/058020 patent/WO2019089465A1/en unknown
-
2023
- 2023-08-10 JP JP2023130593A patent/JP2023144023A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN111683592B (zh) | 使用电化学传感器对分析物进行无校正的体内测量 | |
| Álvarez-Martos et al. | Electrochemical label-free aptasensor for specific analysis of dopamine in serum in the presence of structurally related neurotransmitters | |
| US11202587B2 (en) | Dual-reporter electrochemical sensors with drift correction | |
| Bard et al. | Chemically imaging living cells by scanning electrochemical microscopy | |
| US4805624A (en) | Low-potential electrochemical redox sensors | |
| US8105478B2 (en) | Method for measuring the concentration or change in concentration of a redox-active substance and corresponding device | |
| Suzuki et al. | Micromachined Severinghaus-type carbon dioxide electrode | |
| Stefan et al. | Monocrystalline diamond paste-based electrodes and their applications for the determination of Fe (II) in vitamins | |
| D’Orazio et al. | Electrochemistry and chemical sensors | |
| US11946098B2 (en) | Calibration-free measurement with electrochemical biosensors | |
| CN102667475A (zh) | 用于测量液体样本中的分析物浓度的方法 | |
| Kalimuthu et al. | Selective determination of 3, 4-dihydroxyphenylacetic acid in the presence of ascorbic and uric acids using polymer film modified electrode | |
| JPWO2019089465A5 (zh) | ||
| WO2013164632A1 (en) | Pulsed signal testing of biological fluid | |
| US20220225910A1 (en) | Modulating Electron Transfer Kinetics in E-DNA-type Sensors | |
| Gokavi et al. | Square Wave Voltammetric Determination of 2‐Thiouracil in Pharmaceuticals and Real Samples Using Glassy Carbon Electrode | |
| Herdman et al. | The aqueous deposition of a pH sensitive quinone on carbon paste electrodes using linear sweep voltammetry | |
| Wang et al. | Nitric oxide sensor based on poly (p-phenylenevinylene) derivative modified electrode and its application in rat heart | |
| YAMAUCHI et al. | Enzyme Embodied Electrode= A New Amperometric Biosensing Device | |
| JPH05215712A (ja) | 電気触媒グルコースセンサ | |
| Lewandowksi et al. | Electrocatalytic determination of glucose in a Ringer's solution by pulse-voltammetry | |
| Arteshi et al. | Electroanalytical Determination of Isoniazid in Pharmaceutical Formulation and Human Plasma, Using a Poly (Eriochrome Black-T) Modified Pencil Lead Electrode | |
| Downs | Improving the accuracy and resolution of electrochemical aptamer-based sensors | |
| Şenel | Electrochemistry test strip as platform for ın situ detection of blood levels of antipsychotic clozapine in finger-pricked sample volume | |
| Sheth et al. | Differential linear scan voltammetry: analytical performance in comparison with pulsed voltammetry techniques |